Angill Medichem India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.75 M
- Company Age 41 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
- Revenue Growth %
- Ebitda
- Net Worth -0.03%
- Total Assets %
About Angill Medichem India
Angill Medichem India Private Limited (AMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 December 1983 and has a history of 41 years and one month. Its registered office is in Na, Delhi.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹0.60 M.
Ravi Sinha and Surajmal Dubey serve as directors at the Company.
Company Details
- LocationNa, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232DL1983PTC017080
- Company No.
017080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Angill Medichem India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Sinha  | Additional Director | 06-Jan-2014 | Current |
| Surajmal Dubey | Director | 01-Mar-2004 | Current |
Financial Performance of Angill Medichem India.
Angill Medichem India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Angill Medichem India?
Unlock access to Angill Medichem India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Welkin Properties Private LimitedRavi Sinha and Surajmal Dubey are mutual person
- Welkin Estates Private Limited
Ravi Sinha and Surajmal Dubey are mutual person
- Shivam Buildtech Private Limited
Surajmal Dubey is a mutual person
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 1987 | State Bank Of India | ₹0.60 M | Open |
How Many Employees Work at Angill Medichem India?
Angill Medichem India has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angill Medichem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angill Medichem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
